Robert Dallmann

Robert Dallmann

Auto-generated profile, based on publicly available information

Robert Dallmann

Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RDRobert Dallmann
Robert Dallmann
AVAntoine U. Viola
Antoine U. Viola
LTLeila Tarokh
Leila Tarokh
CCChristian Cajochen
Christian Cajochen
SBSteven A. Brown
Steven A. Brown
The circadian clock orchestrates many aspects of human physiology, and disruption of this clock has been implicated in various pathologies, ranging from cancer to metabolic syndrome and diabetes. Although there is evidence that metabolism and the circadian clockwork are intimately linked on a transcriptional level, whether these effects are directly under clock control or are mediated by the rest–activity cycle and the timing of food intake is unclear. To answer this question, we conducted an unbiased screen in human subjects of the metabolome of blood plasma and saliva at different times of day. To minimize indirect effects, subjects were kept in a 40-h constant routine of enforced posture, constant dim light, hourly isocaloric meals, and sleep deprivation. Under these conditions, we found that ∼15% of all identified metabolites in plasma and saliva were under circadian control, most notably fatty acids in plasma and amino acids in saliva. Our data suggest that there is a strong direct effect of the endogenous circadian clock on multiple human metabolic pathways that is independent of sleep or feeding. In addition, they identify multiple potential small-molecule biomarkers of human circadian phase and sleep pressure.

1 April 2017 in Pharmacological Reviews
Verified
Journal Article
Open access
PDF file
ABAnnabelle Ballesta
Annabelle Ballesta
PIPasquale F. Innominato
Pasquale F. Innominato
RDRobert Dallmann
Robert Dallmann
DRDavid A. Rand
David A. Rand
FLFrancis A. Lévi
Francis A. Lévi
Chronotherapeutics aim at treating illnesses according to the endogenous biologic rhythms, which moderate xenobiotic metabolism and cellular drug response. The molecular clocks present in individual cells involve approximately fifteen clock genes interconnected in regulatory feedback loops. They are coordinated by the suprachiasmatic nuclei, a hypothalamic pacemaker, which also adjusts the circadian rhythms to environmental cycles. As a result, many mechanisms of diseases and drug effects are controlled by the circadian timing system. Thus, the tolerability of nearly 500 medications varies by up to fivefold according to circadian scheduling, both in experimental models and/or patients. Moreover, treatment itself disrupted, maintained, or improved the circadian timing system as a function of drug timing. Improved patient outcomes on circadian-based treatments (chronotherapy) have been demonstrated in randomized clinical trials, especially for cancer and inflammatory diseases. However, recent technological advances have highlighted large interpatient differences in circadian functions resulting in significant variability in chronotherapy response. Such findings advocate for the advancement of personalized chronotherapeutics through interdisciplinary systems approaches. Thus, the combination of mathematical, statistical, technological, experimental, and clinical expertise is now shaping the development of dedicated devices and diagnostic and delivery algorithms enabling treatment individualization. In particular, multiscale systems chronopharmacology approaches currently combine mathematical modeling based on cellular and whole-body physiology to preclinical and clinical investigations toward the design of patient-tailored chronotherapies. We review recent systems research works aiming to the individualization of disease treatment, with emphasis on both cancer management and circadian timing system–resetting strategies for improving chronic disease control and patient outcomes.

1 March 2018 in Cell Metabolism
Verified
Journal Article
Closed access
KSKaren Schmitt
Karen Schmitt
Amandine GrimmAmandine Grimm
Amandine Grimm
RDRobert Dallmann
Robert Dallmann
BOBjoern Oettinghaus
Bjoern Oettinghaus
LRLisa Michelle Restelli
Lisa Michelle Restelli
Anne EckertAnne Eckert
Anne Eckert

1 May 2016 in Trends in Molecular Medicine
Verified
Journal Article
Open access
RDRobert Dallmann
Robert Dallmann
AOAlper Okyar
Alper Okyar
FLFrancis Lévi
Francis Lévi
Daily rhythms in physiology significantly modulate drug pharmacokinetics and pharmacodynamics according to the time-of-day, a finding that has led to the concept of chronopharmacology. The importance of biological clocks for xenobiotic metabolism has gained increased attention with the discovery of the molecular circadian clockwork. Mechanistic understanding of the cell-autonomous molecular circadian oscillator and the circadian timing system as a whole has opened new conceptual and methodological lines of investigation to understand first, the clock's impact on a specific drug's daily variations or the effects/side effects of environmental substances, and second, how clock-controlled pathways are coordinated within a given tissue or organism. Today, there is an increased understanding of the circadian modulation of drug effects. Moreover, several molecular strategies are being developed to treat disease-dependent and drug-induced clock disruptions in humans.

16 February 2014 in Nature Neuroscience
Verified
Journal Article
Closed access
AAAbdelhalim Azzi
Abdelhalim Azzi
RDRobert Dallmann
Robert Dallmann
ACAlison Casserly
Alison Casserly
HRHubert Rehrauer
Hubert Rehrauer
APAndrea Patrignani
Andrea Patrignani
SBSteven A Brown
Steven A Brown

6 January 2014 in Annual Review of Pharmacology and Toxicology
Verified
Journal Article
Closed access
RDRobert Dallmann
Robert Dallmann
SBSteven A. Brown
Steven A. Brown
FGFrederic Gachon
Frederic Gachon
Most facets of mammalian physiology and behavior vary according to time of day, thanks to endogenous circadian clocks. Therefore, it is not surprising that many aspects of pharmacology and toxicology also oscillate according to the same 24-h clocks. Daily oscillations in abundance of proteins necessary for either drug absorption or metabolism result in circadian pharmacokinetics, and oscillations in the physiological systems targeted by these drugs result in circadian pharmacodynamics. These clocks are present in most cells of the body, organized in a hierarchical fashion. Interestingly, some aspects of physiology and behavior are controlled directly via a “master clock” in the suprachiasmatic nuclei of the hypothalamus, whereas others are controlled by “slave” oscillators in separate brain regions or body tissues. Recent research shows that these clocks can respond to different cues and thereby show different phase relationships. Therefore, full prediction of chronopharmacology in pathological contexts will likely require a systems biology approach that considers chronointeractions among different clock-regulated systems.